FDA Inspection 1198954 — Rommelag CDMO GmbH
The FDA completed an inspection of Rommelag CDMO GmbH on Feb 9, 2023 in Sulzbach-Laufen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 9, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Sulzbach-Laufen (Germany)